In silico discovery and therapeutic potential of IDO1 and TDO2 inhibitors.


The war on cancer has traditionally been fought by deploying ever-powerful tactics of killing cancer cells by irradiation, chemoand targeted-therapies. Many hard-fought battles have been won but novel strategies are necessary to declare ultimate victory in the war on cancer. Picking up from where Dr William Cooley left us more than a century ago, a recent… (More)
DOI: 10.4155/fmc-2017-0070


  • Presentations referencing similar topics